-
Clinical Biochemistry Jan 2020Cardiac arrhythmias are associated with substantial morbidity and mortality. Recent advances in the pathophysiological understanding of cardiac arrhythmia indicate that... (Review)
Review
Cardiac arrhythmias are associated with substantial morbidity and mortality. Recent advances in the pathophysiological understanding of cardiac arrhythmia indicate that inflammation, fibrosis, and even autoimmune mechanisms could facilitate the development of arrhythmias by interfering either with fibroblast activation-related electrical remodeling or with the function of different cardiac ion channels, leading to the emerging concepts of autoimmune and inflammatory channelopathies. In this descriptive review, we considered recent data of the literature focusing on biomarkers reflecting the degree of inflammation, myocardial stretch, fibrosis and sustained B-cell activation as potential additional diagnostic, risk stratification tools and potential therapeutic targets in cardiac arrhythmia.
Topics: Arrhythmias, Cardiac; B-Lymphocytes; Biomarkers; Fibrosis; Humans; Inflammation; Lymphocyte Activation; Myocardium
PubMed: 31786205
DOI: 10.1016/j.clinbiochem.2019.11.012 -
Polskie Archiwum Medycyny Wewnetrznej 1992
Comparative Study Review
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Heart Failure; Humans
PubMed: 1492023
DOI: No ID Found -
Methodist DeBakey Cardiovascular Journal 2024Cardiovascular disease significantly jeopardizes pregnancies in the United States, impacting 1% to 4% of pregnancies annually. Among complications, cardiac arrhythmias... (Review)
Review
Cardiovascular disease significantly jeopardizes pregnancies in the United States, impacting 1% to 4% of pregnancies annually. Among complications, cardiac arrhythmias are prevalent, posing concerns for maternal and fetal health. The incidence of arrhythmias during pregnancy is rising, partly due to advances in congenital heart surgery and a growing population of women with structural heart disease. While most arrhythmias are benign, the increasing prevalence of more serious arrhythmias warrants a proactive approach. Guidance and reassurance suffice in many cases, but persistent symptoms require cautious use of antiarrhythmic drugs or other therapies for a safe outcome. Managing more serious arrhythmias requires a comprehensive, multidisciplinary approach involving specialists, including maternal-fetal medicine physicians, cardiologists, electrophysiologists, and anesthesiologists.
Topics: Pregnancy; Female; Humans; United States; Arrhythmias, Cardiac; Anti-Arrhythmia Agents
PubMed: 38495654
DOI: 10.14797/mdcvj.1325 -
Cardiologia (Rome, Italy) Nov 1982
Review
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Electrocardiography; Heart Aneurysm; Heart Diseases; Humans; Monitoring, Physiologic; Postoperative Complications; Prognosis; Surgical Procedures, Operative
PubMed: 6765436
DOI: No ID Found -
Primary Care Sep 2000Sudden cardiac death remains a leading cause of death in the United States. It is usually due to ventricular arrhythmia, either ventricular tachycardia or ventricular... (Review)
Review
Sudden cardiac death remains a leading cause of death in the United States. It is usually due to ventricular arrhythmia, either ventricular tachycardia or ventricular fibrillation. The probability of life threatening ventricular arrhythmia correlates closely with underlying structural heart disease. In any patient presenting with a ventricular arrhythmia, a careful search for underlying causes is required, and treatment should be considered primarily if it will prolong survival. Treatment of patients without underlying heart disease who are experiencing ventricular ectopy, and/or nonsustained ventricular tachycardia, consists of reassurance and education. If symptoms are severe, a beta-blocker is an appropriate choice for drug treatment. Patients with ventricular arrhythmia and structural heart disease are generally best managed in conjunction with a cardiologist.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Ventricles; Humans; Male; Mass Screening; Middle Aged; Sports
PubMed: 10918676
DOI: 10.1016/s0095-4543(05)70170-6 -
Anaesthesia, Resuscitation, and... 1975The authors studied in detail arrhythmias recorded during 110 operations of mitral commissurotomy. In all cases supraventricular and ventricular arrhythmias developed...
The authors studied in detail arrhythmias recorded during 110 operations of mitral commissurotomy. In all cases supraventricular and ventricular arrhythmias developed and their type, as well as frequency, depended on the stage of operation. Life-endangering ventricular arrhythmias (ventricular flutter or fibrillation) were never observed and ventricular tachycardia occurring when the orifice was being dilated always regressed spontaneously when a Dubost dilator was removed. Rapid differential diagnosis of arrhythmias is facilitated greatly by additional ECG recording from oesophageal lead. Indications for pharmacological treatment are discussed. This treatment was used, however, in several cases only.
Topics: Adolescent; Adult; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Bradycardia; Cardiac Surgical Procedures; Child; Diagnosis, Differential; Electrocardiography; Female; Humans; Male; Middle Aged; Mitral Valve Stenosis; Remission, Spontaneous; Tachycardia
PubMed: 1229913
DOI: No ID Found -
Pacing and Clinical Electrophysiology :... Nov 1990
Review
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Pilot Projects; Risk Factors
PubMed: 1702527
DOI: 10.1111/j.1540-8159.1990.tb04028.x -
Nihon Naika Gakkai Zasshi. the Journal... Mar 2006
Review
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Body Surface Potential Mapping; Cardiac Pacing, Artificial; Catheter Ablation; Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography; Humans; Ion Channels; Molecular Diagnostic Techniques
PubMed: 16640085
DOI: 10.2169/naika.95.520 -
Journal of Cardiovascular... Sep 2013
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Female; Heart Conduction System; Humans; Middle Aged
PubMed: 23551694
DOI: 10.1111/jce.12131 -
Nihon Rinsho. Japanese Journal of... Jun 2004
Review
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Defibrillators, Implantable; Heart Block; Humans; Kidney Failure, Chronic; Pacemaker, Artificial; Renal Dialysis
PubMed: 15250301
DOI: No ID Found